Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
June 05, 2017 07:00 ET
|
Immunocore Limited
PRESS RELEASE Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting Median progression free survival (PFS) close to...
Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
June 05, 2017 02:00 ET
|
Immunocore Limited
PRESS RELEASE Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting Median progression free survival (PFS) close to double...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
June 01, 2017 07:00 ET
|
Immunocore Limited
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's...
Immunocore Limited: Abbas Hussain Joins the Board of Immunocore as Non-Executive Director
May 12, 2017 08:00 ET
|
Immunocore Limited
PRESS RELEASE Abbas Hussain Joins the Board of Immunocore as Non-Executive Director Ian T. Clark also appointed as special adviser to the Board (Oxford, UK and Conshohocken, US, 12...
Immunocore Limited: Abbas Hussain Joins the Board of Immunocore as Non-Executive Director
May 12, 2017 02:00 ET
|
Immunocore Limited
PRESS RELEASE Abbas Hussain Joins the Board of Immunocore as Non-Executive Director Ian T. Clark also appointed as special adviser to the Board (Oxford, UK and Conshohocken, US, 12 May...
Immunocore Limited: Immunocore identifies second novel ImmTAC® in the GSK collaboration
May 08, 2017 02:04 ET
|
Immunocore Limited
PRESS RELEASE - IMMUNOCORE LIMITED Immunocore identifies second novel ImmTAC® in the GSK collaboration (Oxford, UK, 8 May 2017) Immunocore Limited, the world's leading TCR company developing...
Immunocore Limited: Appoints Paul Fry as Chief Financial Officer
October 12, 2016 02:10 ET
|
Immunocore Limited
ABINGDON, OXON, United Kingdom, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, infectious diseases and...